£ million unless otherwise indicated | Notes | 2025 | 2024 |
Revenue | 3 | ||
Duty and similar items | ( | ( | |
Other cost of sales | ( | ( | |
Cost of sales | ( | ( | |
Gross profit | |||
Distribution, advertising and selling costs | ( | ( | |
Administrative and other expenses | ( | ( | |
Operating profit | 4 | ||
Investment income | 5 | ||
Finance costs | 5 | ( | ( |
Net finance costs | ( | ( | |
| Share of profit of investments accounted for using | |||
the equity method | 15 | ||
Profit before tax | |||
Tax | 8 | ( | ( |
Profit for the year | |||
| Attributable to: | |||
Owners of the parent | |||
Non-controlling interests | |||
| Earnings per ordinary share (pence) | |||
• Basic | 10 | ||
• Diluted | 10 |
£ million | Notes | 2025 | 2024 |
Profit for the year | |||
| Other comprehensive income | |||
Exchange movements | ( | ( | |
Hyperinflation adjustment in the year | 1 | ||
| Current tax on hedge of net investments | |||
and quasi-equity loans | ( | ||
Items that may be reclassified to profit and loss | ( | ||
Net actuarial losses on retirement benefits | 24 | ( | ( |
| Deferred tax relating to net actuarial losses | |||
on retirement benefits | ( | ||
Items that will not be reclassified to profit and loss | ( | ( | |
| Other comprehensive income/(expense) | |||
for the year, net of tax | ( | ||
Total comprehensive income for the year | |||
| Attributable to: | |||
Owners of the parent | |||
Non-controlling interests | |||
Total comprehensive income for the year |
£ million | Notes | 2025 | 2024 |
| Non-current assets | |||
Intangible assets | 12 | ||
Property, plant and equipment | 13 | ||
Right of use assets | 14 | ||
Investments accounted for using the equity method | 15 | ||
Retirement benefit assets | 24 | ||
Trade and other receivables | 17 | ||
Derivative financial instruments | 21/22 | ||
Deferred tax assets | 23 | ||
| Current assets | |||
Inventories | 16 | ||
Trade and other receivables | 17 | ||
Current tax assets | 8 | ||
Cash and cash equivalents | 18 | ||
Derivative financial instruments | 21/22 | ||
Total assets | |||
| Current liabilities | |||
Borrowings | 20 | ( | ( |
Derivative financial instruments | 21/22 | ( | ( |
Lease liabilities | 14 | ( | ( |
Trade and other payables | 19 | ( | ( |
Current tax liabilities | 8 | ( | ( |
Provisions | 25 | ( | ( |
( | ( |
£ million | Notes | 2025 | 2024 |
| Non-current liabilities | |||
Borrowings | 20 | ( | ( |
Derivative financial instruments | 21/22 | ( | ( |
Lease liabilities | 14 | ( | ( |
Trade and other payables | 19 | ( | ( |
Deferred tax liabilities | 23 | ( | ( |
Retirement benefit liabilities | 24 | ( | ( |
Provisions | 25 | ( | ( |
( | ( | ||
Total liabilities | ( | ( | |
Net assets | |||
| Equity | |||
Share capital | 26 | ||
Share premium and capital redemption | 26 | ||
Retained earnings | ( | ( | |
Exchange translation reserve | ( | ||
Equity attributable to owners of the parent | |||
Non-controlling interests | |||
Total equity |
| Equity | |||||||
| Share premium | Exchange | attributable | |||||
| and capital | Retained | translation | to owners of | Non- controlling | |||
£ million | Share capital | redemption | earnings | reserve | the parent | interests | Total equity |
At | ( | ( | |||||
Profit for the year | |||||||
Exchange movements on retranslation of net assets | |||||||
Exchange movements on net investment hedges | ( | ( | ( | ||||
Exchange movements on quasi-equity loans | ( | ( | ( | ||||
Hyperinflation adjustment in the year | |||||||
Current tax on hedge of net investments and quasi-equity loans | |||||||
Net actuarial losses on retirement benefits | ( | ( | ( | ||||
Deferred tax relating to net actuarial losses on retirement benefits | ( | ( | ( | ||||
Other comprehensive income/(expense) | ( | ||||||
Total comprehensive income | |||||||
| Transactions with owners | |||||||
Costs of employees’ services compensated by share schemes | |||||||
Contributions relating to share schemes | |||||||
Repurchase of shares | ( | ( | ( | ( | |||
Changes in non-controlling interests | |||||||
Deferred tax on share-based payments | |||||||
Dividends paid | ( | ( | ( | ( | |||
At | ( |
| Equity | |||||||
| Share premium | Exchange | attributable | |||||
| and capital | Retained | translation | to owners of | Non- controlling | |||
£ million | Share capital | redemption | earnings | reserve | the parent | interests | Total equity |
At 1 October 2023 | ( | ||||||
Profit for the year | |||||||
Exchange movements on retranslation of net assets | ( | ( | ( | ( | |||
Exchange movements on net investment hedges | |||||||
Exchange movements on quasi-equity loans | |||||||
Hyperinflation adjustment in the year | |||||||
Current tax on hedge of net investments and quasi-equity loans | ( | ( | ( | ||||
Net actuarial losses on retirement benefits | ( | ( | ( | ||||
Deferred tax relating to net actuarial losses on retirement benefits | |||||||
Other comprehensive expense | ( | ( | ( | ( | ( | ||
Total comprehensive income/(expense) | ( | ||||||
| Transactions with owners | |||||||
Costs of employees’ services compensated by share schemes | |||||||
Current tax on share-based payments | |||||||
Repurchase of shares | ( | ( | ( | ( | |||
Changes in non-controlling interests | ( | ( | ( | ( | |||
Deferred tax on share-based payments | |||||||
Remeasurement of put/call option | |||||||
Dividends paid | ( | ( | ( | ( | |||
At 30 September 2024 | ( | ( |
£ million | 2025 | 2024 |
| Cash flows from operating activities | ||
Operating profit | ||
| Dividends received from investments accounted for using | ||
the equity method | ||
Depreciation, amortisation and impairment | ||
Profit on disposal of non-current assets | ( | ( |
Post-employment benefits | ( | ( |
Share-based payments | ||
Other non-cash items | ( | ( |
Movement in provisions | ( | ( |
Operating cash flows before movement in working capital | ||
(Increase)/decrease in inventories | ( | |
Decrease/(increase) in trade and other receivables | ( | |
Increase in trade and other payables | ||
Movement in working capital | ( | |
Tax paid | ( | ( |
Net cash generated from operating activities | ||
| Cash flows from investing activities | ||
Interest received | ||
Proceeds from the sale of non-current assets | ||
Purchase of property, plant and equipment | ( | ( |
Purchase of intangibles | ( | ( |
Purchase of brands and operations | ( | ( |
Net cash used in investing activities | ( | ( |
£ million | 2025 | 2024 |
| Cash flows from financing activities | ||
Acquisition of non-controlling interests | ( | |
Interest paid | ( | ( |
Lease liabilities paid | ( | ( |
Contributions relating to share schemes | ||
Increase in borrowings | ||
Repayment of borrowings | ( | ( |
Cash flows relating to derivative financial instruments | ( | ( |
Repurchase of shares | ( | ( |
Dividends paid to non-controlling interests | ( | ( |
Dividends paid to owners of the parent | ( | ( |
Net cash used in financing activities | ( | ( |
Net increase/(decrease) in cash and cash equivalents | ( | |
Cash and cash equivalents at start of year | ||
Effect of foreign exchange rates on cash and cash equivalents | ( | |
Cash and cash equivalents at end of year |
2025 | 2024 | |||
Closing rate | Average rate | Closing rate | Average rate | |
Euro | 1.1459 | 1.1824 | 1.1985 | 1.1694 |
US dollar | 1.3439 | 1.3064 | 1.3384 | 1.2681 |
2025 | 2024 | |||||
| Tobacco & | Tob acco & | |||||
£ million unless otherwise indicated | Tobacco | NGP | NGP | Tobacco | NGP | NGP |
Revenue | 21,071 | 432 | 21,503 | 21,708 | 376 | 22,084 |
Net revenue | 7,948 | 368 | 8,316 | 7,828 | 329 | 8,157 |
Operating profit/(loss) | 3,299 | (121) | 3,178 | 3,321 | (83) | 3,238 |
Adjusted operating profit | 3,665 | 3,587 | ||||
Adjusted operating margin % | 44.1 | 44.0 |
£ million unless otherwise indicated | 2025 | 2024 |
Revenue | 11,448 | 11,104 |
Distribution gross profit | 1,530 | 1,503 |
Operating profit | 305 | 322 |
Adjusted operating profit | 316 | 330 |
Adjusted operating margin % | 20.7 | 22.0 |
2025 | 2024 | |||
| Total | External | Total | External | |
| £ million | revenue | revenue | revenue | revenue |
| Tobacco & NGP | ||||
Europe | 11,960 | 11,180 | 12,037 | 11,260 |
Americas | 3,652 | 3,652 | 3,657 | 3,657 |
AAACE | 5,891 | 5,891 | 6,390 | 6,390 |
Total Tobacco & NGP | 21,503 | 20,723 | 22,084 | 21,307 |
Distribution | 11,448 | 11,448 | 11,104 | 11,104 |
Eliminations | (780) | - | (777) | - |
Total Group | 32,171 | 32,171 | 32,411 | 32,411 |
2025 | 2024 | |||||
£ million | Tobacco | NGP | Total | Tobacco | NGP | Total |
Europe | 3,196 | 280 | 3,476 | 3,106 | 260 | 3,366 |
Americas | 2,822 | 70 | 2,892 | 2,793 | 43 | 2,836 |
AAACE | 1,930 | 18 | 1,948 | 1,929 | 26 | 1,955 |
| Total Tobacco | ||||||
& NGP | 7,948 | 368 | 8,316 | 7,828 | 329 | 8,157 |
£ million | 2025 | 2024 | |
| Tobacco & NGP | |||
Europe | 1,638 | 1,541 | |
Americas | 1,233 | 1,235 | |
AAACE | 794 | 811 | |
Total Tobacco & NGP | 3,665 | 3,587 | |
Distribution | 316 | 330 | |
Eliminations | 7 | (6) | |
Adjusted operating profit | 3,988 | 3,911 | |
Amortisation and impairment of acquired intangibles - Tobacco & NGP | (358) | (345) | |
Amortisation of acquired intangibles - Distribution | (11) | (8) | |
2030 | Strategy implementation costs | (21) | - |
2030 | Strategy non-cash costs | (101) | - |
Structural changes to defined benefit pension schemes - Tobacco & NGP | (7) | (4) | |
Operating profit | 3,490 | 3,554 | |
Net finance costs | (374) | (534) | |
Share of profit of investments accounted for using the equity method | 12 | 9 | |
Profit before tax | 3,128 | 3,029 |
| 2025 | |||||
| Depreciation, | |||||
| Additions to | Additions to | impairment and | Other | ||
| property, plant | intangible | software | intangible asset | Inventory | |
| £ million | and equipment | assets | amortisation | amortisation | impairments |
| Tobacco & NGP | |||||
Europe | 52 | 30 | 185 | 7 | 28 |
Americas | 24 | 199 | 31 | 1 | 10 |
AAACE | 68 | 14 | 44 | - | 11 |
Total Tobacco & NGP | 144 | 243 | 260 | 8 | 49 |
Distribution | 43 | 8 | 38 | - | - |
Total Group | 187 | 251 | 298 | 8 | 49 |
| 2024 | |||||
| Depreciation, | |||||
| Additions to | Additions to | impairment and | Other | ||
| property, plant | intangible | software | intangible asset | Inventory | |
| £ million | and equipment | assets | amortisation | amortisation | impairments |
| Tobacco & NGP | |||||
Europe | 60 | 17 | 88 | 7 | 16 |
Americas | 30 | 228 | 27 | 1 | 4 |
AAACE | 51 | 3 | 40 | - | 11 |
Total Tobacco & NGP | 141 | 248 | 155 | 8 | 31 |
Distribution | 38 | 12 | 37 | - | - |
Total Group | 179 | 260 | 192 | 8 | 31 |
2025 | 2024 | |||
| External | Non-current | External | Non-current | |
| £ million | revenue | assets | revenue | assets |
UK | 3,261 | 165 | 3,781 | 161 |
Germany | 4,903 | 2,808 | 4,501 | 3,156 |
France | 3,232 | 2,360 | 3,374 | 2,282 |
USA | 3,632 | 4,826 | 3,648 | 4,968 |
Other | 17,143 | 8,012 | 17,1 07 | 7,350 |
Total Group | 32,171 | 18,171 | 32,411 | 17,917 |
£ million | 2025 | 2024 |
Raw materials and consumables used | 1,230 | 950 |
Changes in inventories of finished goods - Tobacco & NGP | 2,466 | 2,516 |
Changes in inventories of finished goods - Distribution | 8,288 | 8,243 |
Depreciation and impairment of fixed assets | 255 | 153 |
| Amortisation and impairment of intangible assets and investments | ||
accounted for using the equity method | 425 | 399 |
Expenses relating to short-term leases | 6 | 10 |
Expenses relating to low value asset leases | 1 | 2 |
Depreciation and impairment of right of use assets | 101 | 95 |
Net foreign exchange losses and (gains) | 2 | (3) |
Write down of inventories | 49 | 28 |
Profit on disposal of non-current assets | 15 | 13 |
Write down/(back) of trade receivables | 10 | (3) |
£ million | 2025 | 2024 |
Parent Company and consolidated financial statements | 3.2 | 3.2 |
The Company’s subsidiaries | 7.1 | 6.8 |
Total audit fees | 10.3 | 10.0 |
Audit-related assurance services | 0.5 | 0.5 |
Total audit-related fees | 10.8 | 10.5 |
Other assurance services | 0.8 | 1.2 |
Total non-audit fees | 0.8 | 1.2 |
Total auditor’s remuneration | 11.6 | 11.7 |
£ million | 2025 | 2024 |
| Investment income | ||
Fair value gains on derivative financial instruments | 227 | 513 |
Net exchange gains on financing activities | 5 | 9 |
Interest income on net defined benefit assets | 18 | 22 |
Interest income on bank deposits | 14 | 16 |
Tax settlement interest income | 38 | - |
Total investment income | 302 | 560 |
| Finance costs | ||
Fair value losses on derivative financial instruments | (219) | (632) |
Interest cost on net defined benefit liabilities | (29) | (33) |
Tax interest cost | - | (10) |
Interest cost on lease liabilities | (15) | (14) |
Interest cost on bank and other loans | (412) | (404) |
Effect of discounting on long-term provisions | (1) | (1) |
Total finance costs | (676) | (1,094) |
Net finance costs | (374) | (534) |
2025 | 2024 | ||||
£ million | Costs | Cash spend | Costs | Cash spend | |
2030 | Strategy Review Programme | 122 | 21 | - | - |
2021 | Strategic Review Programme | - | 19 | - | 25 |
Other | - | 10 | - | 18 | |
122 | 50 | - | 43 |
£ million | 2025 | 2024 |
Wages and salaries | 967 | 923 |
Social security costs | 219 | 202 |
Other pension costs (note 24) | 50 | 29 |
1,236 | 1,154 | |
Share-based payments (note 27) | 36 | 32 |
1,272 | 1,186 |
£ million | 2025 | 2024 |
Base salary | 5.4 | 4.6 |
Benefits | 0.8 | 0.7 |
Pension salary supplement | 0.6 | 0.6 |
Bonus | 4.7 | 4.9 |
Termination payments | - | 0.2 |
LTIP annual vesting 1 | 8.0 | 7. 2 |
19.5 | 18.2 |
£ million | 2025 | 2024 |
Short-term employee benefits | 17.8 | 17.7 |
Termination payments | - | 0.2 |
Share-based payments (in accordance with IAS 24) | 14.9 | 14.4 |
32.7 | 32.3 |
| At 30 | 2025 | At 30 | 2024 | |
September | Average | September | Average | |
Tobacco & NGP | 18,700 | 18,800 | 18,900 | 18,400 |
Distribution | 6,400 | 7,000 | 6,700 | 6,500 |
25,100 | 25,600 | 24,900 |
| At 30 | 2025 | At 30 | 2024 | |
September | Average | September | Average | |
UK and European Union | 12,000 | 12,600 | 12,400 | 12,100 |
Americas | 4,700 | 4,900 | 4,900 | 4,700 |
Rest of the World | 8,400 | 8,300 | 8,300 | 8,100 |
25,100 | 25,800 | 25,600 | 24,900 |
£ million | 2025 | 2024 |
| UK current tax | ||
Current year charged/(credited) to the consolidated income statement | 275 | (95) |
Current year (credited)/charged to consolidated other comprehensive income | (156) | 197 |
Total current year UK current tax | 119 | 102 |
| Adjustments in respect of prior years charged/(credited) | ||
to the consolidated income statement | 5 | (80) |
Total UK current tax | 124 | 22 |
| Overseas current tax | ||
Current year charged to the consolidated income statement | 708 | 704 |
Total current year overseas current tax | 708 | 704 |
| Adjustments in respect of prior years (credited)/charged | ||
to the consolidated income statement | (67) | 40 |
641 | 744 | |
| Total current tax charged to the consolidated statement | ||
of comprehensive income | 765 | 766 |
£ million | 2025 | 2024 |
| UK current tax | ||
Current year | 275 | (95) |
Adjustments in respect of prior years | 5 | (80) |
| Overseas current tax | ||
Current year | 708 | 704 |
Adjustments in respect of prior years | (67) | 40 |
Total current tax | 921 | 569 |
| Deferred tax | ||
Relating to origination and reversal of temporary differences | (13) | (287) |
Total tax charged to the consolidated income statement | 908 | 282 |
£ million | 2025 | 2024 |
| Tax related to items recognised in consolidated | ||
| other comprehensive income during the year: | ||
| Current tax (credited)/charged on hedge of net investment | ||
and quasi-equity loans | (156) | 197 |
Total current tax | (156) | 197 |
Deferred tax on actuarial gains and losses | 5 | (37) |
Deferred tax on hyperinflation adjustment | (1) | 2 |
Total deferred tax | 4 | (35) |
Total tax (credited)/charged to consolidated other comprehensive income | (152) | 162 |
£ million | 2025 | 2024 |
| Tax related to items recognised in equity during the year: | ||
Current tax on share-based payments | - | (4) |
Deferred tax on share-based payments | (4) | (2) |
Total tax credited to equity | (4) | (6) |
£ million | 2025 | 2024 |
Profit before tax | 3,128 | 3,029 |
Tax at the UK corporation tax rate of 25.0% (2024: 25.0%) | 782 | 757 |
| Tax effects of: | ||
Differences in effective tax rates on overseas earnings | (2) | (56) |
Movement in provision for uncertain tax positions | (62) | 170 |
| Remeasurement of deferred tax balances arising | ||
from changes in tax rates | (3) | 5 |
Recognition of deferred tax assets for tax credits | - | (293) |
Remeasurement of previously recognised deferred tax assets | (3) | (2) |
Deferred tax on unremitted earnings | 19 | 12 |
Share of profit of investments accounted for using the equity method | (3) | (2) |
Non-deductible expenses | 38 | 24 |
Non-taxable gains on net foreign exchange on financial instruments | 165 | (198) |
Provision for state aid tax recoverable | - | (101) |
Adjustments in respect of prior years | (23) | (34) |
Total tax charged to the consolidated income statement | 908 | 282 |
£ million | 2025 | 2024 |
At 1 October | (163) | (306) |
Charged to the consolidated income statement | (921) | (569) |
Credited/(Charged) to other comprehensive income | 156 | (197) |
Credited to equity | - | 4 |
Cash paid | 513 | 888 |
Exchange movements | (11) | 17 |
At 30 September | (426) | (163) |
£ million | 2025 | 2024 |
State aid tax recoverable | - | 101 |
Current tax assets | 146 | 148 |
Current tax liabilities | (572) | (412) |
(426) | (163) |
Pence per share | £ million | |||||
2025 | 2024 | 2023 | 2025 | 2024 | 2023 | |
| Cash: | ||||||
December | 54.26 | 51.82 | 49.31 | 455 | 461 | 464 |
March | 54.26 | 51.82 | 49.32 | 451 | 453 | 457 |
June | 40.08 | 22.45 | 21.59 | 328 | 193 | 196 |
September | 40.08 | 22.45 | 21.59 | 324 | 192 | 195 |
Total | 188.68 | 148.54 | 141.81 | 1,558 | 1,299 | 1,312 |
£ million | 2025 | 2024 |
| Earnings: basic and diluted - attributable to owners | ||
of the Parent Company | 2,071 | 2,613 |
| Millions of shares | ||
| Weighted average number of shares: | ||
Shares for basic earnings per share | 824.8 | 869.0 |
Potentially dilutive share options | 5.8 | 4.9 |
Shares for diluted earnings per share | 830.6 | 873.9 |
| Pence | ||
Basic earnings per share | 251.1 | 300.7 |
Diluted earnings per share | 249.3 | 299.0 |
| 2025 | |||||
| Intellectual | |||||
| property and | |||||
| product | Supply | ||||
£ million | Goodwill | development | agreements | Software | Total |
| Cost | |||||
At 1 October 2024 | 13,184 | 12,343 | 1,407 | 722 | 27,656 |
Additions | - | 81 | 29 | 141 | 251 |
Disposals | - | - | - | (3) | (3) |
Other movements | - | (48) | - | - | (48) |
Reclassifications | - | - | - | 5 | 5 |
Exchange movements | 489 | 238 | 68 | 18 | 813 |
At 30 September 2025 | 13,673 | 12,614 | 1,504 | 883 | 28,674 |
Amortisation and impairment | |||||
At 1 October 2024 | 1,500 | 8,479 | 1,346 | 393 | 11,718 |
| Amortisation charge | |||||
for the year | - | 370 | 7 | 42 | 419 |
Impairment | - | - | 5 | 1 | 6 |
Disposals | - | - | - | (3) | (3) |
Reclassifications | - | - | - | 3 | 3 |
Exchange movements | 67 | 176 | 66 | 14 | 323 |
Accumulated amortisation | - | 8,486 | 1,419 | 450 | 10,355 |
Accumulated impairment | 1,567 | 539 | 5 | - | 2,111 |
At 30 September 2025 | 1,567 | 9,025 | 1,424 | 450 | 12,466 |
| Net book value | |||||
At 30 September 2025 | 12,106 | 3,589 | 80 | 433 | 16,208 |
| 2024 | |||||
| Intellectual | |||||
| property and | |||||
| product | Supply | ||||
£ million | Goodwill | development | agreements | Software | Total |
| Cost | |||||
At 1 October 2023 | 13,785 | 13,042 | 1,457 | 630 | 28,914 |
Additions | - | 115 | 2 | 143 | 260 |
Acquisitions | 2 | 1 | 2 | - | 5 |
Disposals | - | (1) | (2) | (4) | (7) |
Reclassifications | 29 | - | 1 | (30) | - |
Exchange movements | (632) | (814) | (53) | (17) | (1,516) |
At 30 September 2024 | 13,184 | 12,343 | 1,407 | 722 | 27,656 |
Amortisation and impairment | |||||
At 1 October 2023 | 1,556 | 8,650 | 1,389 | 375 | 11,970 |
| Amortisation charge | |||||
for the year | - | 354 | 7 | 38 | 399 |
Disposals | - | - | - | (3) | (3) |
Exchange movements | (56) | (525) | (50) | (17) | (648) |
Accumulated amortisation | - | 7,940 | 1,346 | 392 | 9,678 |
Accumulated impairment | 1,500 | 539 | - | 1 | 2,040 |
At 30 September 2024 | 1,500 | 8,479 | 1,346 | 393 | 11,718 |
| Net book value | |||||
At 30 September 2024 | 11,684 | 3,864 | 61 | 329 | 15,938 |
| Assets under construction | |||||
| included above: | |||||
At 30 September 2025 | 352 | ||||
At 30 September 2024 | 261 |
2025 | 2024 | |||
| Intangible | Intangible | |||
| assets with | assets with | |||
£ million | Goodwill | indefinite lives | Goodwill | indefinite lives |
Europe | 4,055 | 309 | 3,919 | 296 |
Americas | 4,081 | - | 3,945 | - |
AAACE | 2,147 | 163 | 2,076 | 156 |
Tobacco & NGP | 10,283 | 472 | 9,940 | 452 |
Distribution | 1,823 | - | 1,744 | - |
12,106 | 472 | 11,684 | 452 |
2025 | 2024 | |||||
| Pre-tax | Initial | Long-term | Pre-tax | Initial | Long-term | |
| % | discount rate | growth rate | growth rate | discount rate | growth rate | growth rate |
Europe | 10.6 | 2.3 | 0.5 | 9.9 | 4.1 | 0.2 |
Americas | 9.2 | 5.7 | 2.1 | 8.7 | 6.5 | 1.9 |
AAACE | 13.1 | 3.5 | 2.0 | 13.3 | 2.0 | 1.9 |
Distribution | 11.5 | 6.3 | 1.6 | 12.1 | 4.1 | 1.6 |
| Plant and | Fixtures and | 2025 | ||
£ million | Property | equipment | motor vehicles | Total |
| Cost | ||||
At 1 October 2024 | 736 | 2,048 | 450 | 3,234 |
Additions | 11 | 144 | 32 | 187 |
Acquisitions | 1 | 2 | 3 | 6 |
Disposals | (32) | (64) | (31) | (127) |
Hyperinflation adjustment | - | 4 | - | 4 |
Reclassifications | 8 | (31) | 23 | - |
Exchange movements | 28 | 78 | 14 | 120 |
At 30 September 2025 | 752 | 2,181 | 491 | 3,424 |
| Depreciation and impairment | ||||
At 1 October 2024 | 168 | 1,222 | 283 | 1,673 |
Depreciation charge for the year | 14 | 100 | 41 | 155 |
Impairment | 12 | 75 | 13 | 100 |
Disposals | (18) | (51) | (26) | (95) |
Reclassifications | 7 | (10) | 3 | - |
Exchange movements | 9 | 46 | 12 | 67 |
At 30 September 2025 | 192 | 1,382 | 326 | 1,900 |
| Net book value | ||||
At 30 September 2025 | 560 | 799 | 165 | 1,524 |
| 2024 | ||||
| Plant and | Fixtures and | |||
£ million | Property | equipment | motor vehicles | Total |
| Cost | ||||
At 1 October 2023 | 756 | 2,065 | 484 | 3,305 |
Additions | 10 | 127 | 41 | 178 |
Acquisitions | - | 1 | - | 1 |
Disposals | (24) | (69) | (48) | (141) |
Hyperinflation adjustment | 1 | 10 | 1 | 12 |
Reclassifications | 18 | (5) | (13) | - |
Exchange movements | (25) | (81) | (15) | (121) |
At 30 September 2024 | 736 | 2,048 | 450 | 3,234 |
| Depreciation and impairment | ||||
At 1 October 2023 | 177 | 1,203 | 308 | 1,688 |
Depreciation charge for the year | 16 | 102 | 36 | 154 |
Impairment | (3) | 2 | - | (1) |
Disposals | (12) | (47) | (46) | (105) |
Reclassifications | - | 4 | (4) | - |
Exchange movements | (10) | (42) | (11) | (63) |
At 30 September 2024 | 168 | 1,222 | 283 | 1,673 |
| Net book value | ||||
At 30 September 2024 | 568 | 826 | 167 | 1,561 |
| Assets under construction | ||||
| included above: | ||||
At 30 September 2025 | 156 | |||
At 30 September 2024 | 122 |
| Plant and | Fixtures and | 2025 | ||
£ million | Property | equipment | motor vehicles | Total |
| Net book value | ||||
At 1 October 2024 | 267 | 2 | 93 | 362 |
Additions and modifications | 59 | 4 | 43 | 106 |
Terminations | (3) | (1) | (4) | (8) |
Depreciation and impairment | (59) | (3) | (39) | (101) |
Exchange movements | 10 | - | 4 | 14 |
At 30 September 2025 | 274 | 2 | 97 | 373 |
£ million | Lease Liabilities |
At 1 October 2024 | 386 |
Cash flow | (109) |
Accretion of interest | 15 |
New leases, terminations and modifications | 95 |
Exchange movements | 15 |
At 30 September 2025 | 402 |
£ million | 2025 | 2024 |
Expenses relating to short-term leases | 6 | 10 |
Expenses relating to low value asset leases | 1 | 2 |
Depreciation and impairment expense of right of use assets | 101 | 95 |
Interest on lease liabilities | 15 | 14 |
| 2024 | ||||
| Plant and | Fixtures and | |||
£ million | Property | equipment | motor vehicles | Total |
| Net book value | ||||
At 1 October 2023 | 256 | 2 | 68 | 326 |
Additions and modifications | 82 | 4 | 69 | 155 |
Terminations | (4) | (1) | (5) | (10) |
Depreciation | (57) | (3) | (35) | (95) |
Exchange movements | (10) | - | (4) | (14) |
At 30 September 2024 | 267 | 2 | 93 | 362 |
£ million | Lease Liabilities |
At 1 October 2023 | 349 |
Cash flow | (107) |
Accretion of interest | 14 |
New leases, terminations and modifications | 144 |
Exchange movements | (14) |
At 30 September 2024 | 386 |
| Global Horizon | 2025 | ||
| £ million | Ventures | Others | Total |
Revenue | 28 | 40 | 68 |
Profit after tax | 24 | 1 | 25 |
Non-current assets | - | 9 | 9 |
Current assets | 62 | 59 | 121 |
Total assets | 62 | 68 | 130 |
Current liabilities | (5) | (54) | (59) |
Non-current liabilities | - | (14) | (14) |
Total liabilities | (5) | (68) | (73) |
Net assets | 57 | - | 57 |
| 2024 | |||
| Global Horizon | |||
| £ million | Ventures | Others | Total |
Revenue | 25 | 40 | 65 |
Profit after tax | 17 | 3 | 20 |
Non-current assets | - | 8 | 8 |
Current assets | 60 | 62 | 122 |
Total assets | 60 | 70 | 130 |
Current liabilities | (11) | (56) | (67) |
Non-current liabilities | - | (13) | (13) |
Total liabilities | (11) | (69) | (80) |
Net assets | 49 | 1 | 50 |
£ million | 2025 | 2024 |
Purchases from | 15 | 9 |
Accounts payable to | (11) | (4) |
£ million | 2025 | 2024 |
At 1 October | 56 | 55 |
Share of profit for the year from joint ventures | 12 | 9 |
Share of profit for the year from associates | 5 | 1 |
Dividends | (7) | (9) |
At 30 September | 66 | 56 |
£ million | 2025 | 2024 |
Raw materials | 992 | 960 |
Work in progress | 83 | 84 |
Finished inventories | 3,207 | 2,887 |
Other inventories | 184 | 149 |
4,466 | 4,080 |
2025 | 2024 | |||
£ million | Current | Non-current | Current | Non-current |
Trade receivables | 2,446 | 4 | 2,395 | 1 |
Less: loss allowance | (66) | (1) | (64) | (1) |
Net trade receivables | 2,380 | 3 | 2,331 | - |
Other receivables | 205 | 32 | 156 | 37 |
Prepayments | 131 | 98 | 158 | 81 |
2,716 | 133 | 2,645 | 118 |
2025 | 2024 | |||
£ million | Current | Non-current | Current | Non-current |
Within credit terms | 2,228 | 3 | 2,194 | - |
Past due by less than 3 months | 118 | - | 111 | - |
Past due by more than 3 months | 34 | - | 26 | - |
Amounts that are impaired | 66 | 1 | 64 | 1 |
2,446 | 4 | 2,395 | 1 |
£ million | 2025 | 2024 |
At 1 October | 65 | 66 |
Net increase/(decrease) in provision | 2 | (1) |
At 30 September | 67 | 65 |
£ million | 2025 | 2024 |
Cash at bank and in hand | 683 | 607 |
Short-term deposits and other liquid assets | 756 | 471 |
1,439 | 1,078 |
2025 | 2024 | |||
£ million | Current | Non-current | Current | Non-current |
Trade payables | 1,709 | - | 1,499 | - |
Duties payable | 5,225 | - | 5,156 | - |
| Other taxes and social security | ||||
contributions | 1,532 | - | 1,381 | - |
Other payables | 607 | - | 623 | - |
Accruals | 967 | 41 | 838 | 86 |
10,040 | 41 | 9,497 | 86 |
£ million | 2025 | 2024 |
| Current borrowings | ||
Bank loans and overdrafts | 4 | 34 |
| Capital market issuance: | ||
European commercial paper (ECP) | - | 21 |
€500m 1.375% notes due January 2025 | - | 421 |
US$ 950m 4.25% notes due July 2025 | - | 715 |
€650m 3.375% notes due February 2026 | 579 | - |
US$ 400m 3.5% notes due July 2026 | 300 | - |
£188m 5.5% notes due September 2026 | 187 | - |
Total current borrowings | 1,070 | 1,191 |
| Non-current borrowings | ||
| Capital market issuance: | ||
€650m 3.375% notes due February 2026 | - | 553 |
US$ 750m 3.5% notes due July 2026 | - | 563 |
£500m 5.5% notes due September 2026 | - | 500 |
€750m 2.125% notes due February 2027 | 663 | 634 |
US$ 1,000m 6.125% notes due July 2027 | 750 | 752 |
US$ 850m 4.5% notes due June 2028 | 638 | - |
US$ 1,000m 3.875% notes due July 2029 | 748 | 751 |
US$ 1,250m 5.5% notes due February 2030 | 936 | 944 |
€1,050m 5.25% notes due February 2031 | 940 | 898 |
£500m 4.875% notes due June 2032 | 506 | 505 |
€1,000m 1.75% notes due March 2033 | 879 | 840 |
€1,000m 3.875% notes due February 2034 | 886 | - |
US$ 750m 5.875% notes due July 2034 | 564 | 566 |
US$ 850m 5.625% notes due July 2035 | 639 | - |
US$ 500m 6.375% notes due July 2055 | 375 | - |
Total non-current borrowings | 8,524 | 7,506 |
Total borrowings | 9,594 | 8,697 |
| Analysed as: | ||
Capital market issuance | 9,590 | 8,663 |
Bank loans and overdrafts | 4 | 34 |
| Balance sheet | 2025 | Balance sheet | 2024 | |
| £ million | amount | Fair value | amount | Fair value |
GBP | 693 | 671 | 1,006 | 985 |
EUR | 3,947 | 3,839 | 3,367 | 3,245 |
USD | 4,950 | 5,012 | 4,290 | 4,303 |
Total capital market issuance | 9,590 | 9,522 | 8,663 | 8,533 |
£ million | 2025 | 2024 |
| Amounts maturing: | ||
In less than one year | 700 | 853 |
Between one and two years | - | 153 |
Between two and five years | 2,619 | 2,608 |
3,319 | 3,614 |
2025 | 2024 | |
| Increase/ | Increase/ | |
| (decrease) in | (decrease) in | |
| £ million | income | income |
| Income statement impact of non-functional currency foreign | ||
| exchange exposures: | ||
10% appreciation of sterling against euro (2024: 10%) | 78 | 87 |
10% appreciation of sterling against US dollar (2024: 10%) | (25) | (17) |
10% depreciation of sterling against euro (2024: 10%) | (95) | (106) |
10% depreciation of sterling against US dollar (2024: 10%) | 31 | 20 |
2025 | 2024 | |
£ million | Change in equity | Change in equity |
| Equity impact of non-functional currency foreign exchange | ||
| exposures: | ||
10% appreciation of sterling against euro (2024: 10%) | 934 | 928 |
10% appreciation of sterling against US dollar (2024: 10%) | 328 | 272 |
10% depreciation of sterling against euro (2024: 10%) | (1,141) | (1,134) |
10% depreciation of sterling against US dollar (2024: 10%) | (401) | (332) |
2025 | 2024 | |
| Change in | Change in | |
| £ million | income | income |
| Income statement impact of interest rate movements: | ||
+/- 1% increase in euro interest rates (2024: 1%) | - | 1 |
+/- 1% increase in US dollar interest rates (2024: 1%) | (9) | (2) |
2025 | 2024 | |
Carrying amount of liabilities that are part of supplier financing arrangements | £ million | £ million |
Presented within trade and other payables | 84 | 3 |
- of which suppliers have received payment from finance provider | 58 | 1 |
| 2025 | |
Range of payment due dates | Days |
Liabilities that are part of the arrangement | 1 - 183 |
Trade payables that are not part of an arrangement | 0 - 120 |
2025 | 2024 | |
| Maximum | Maximum | |
| exposure to | exposure to | |
| credit risk £ | credit risk £ | |
| Counterparty exposure | million | million |
Highest | 515 | 253 |
2nd highest | 87 | 134 |
3rd highest | 73 | 50 |
4th highest | 27 | 27 |
5th highest | 19 | 10 |
| 2025 | ||||||
| Balance | Contractual | |||||
| sheet | cash flows | Between 1 | Between 2 | |||
| £ million | amount | total | <1 year | and 2 years | and 5 years | > 5 years |
| Non-derivative | ||||||
| financial liabilities: | ||||||
Bank loans | 4 | 4 | 4 | - | - | - |
Capital market issuance | 9,590 | 12,181 | 1,462 | 1,763 | 3,141 | 5,815 |
Trade payables | 1,709 | 1,709 | 1,709 | - | - | - |
Accruals | 1,008 | 1,008 | 967 | 17 | 24 | - |
Other contractual liabilities | 607 | 607 | 607 | - | - | - |
Lease liabilities | 402 | 456 | 108 | 86 | 156 | 106 |
| Total non-derivative | ||||||
financial liabilities | 13,320 | 15,965 | 4,857 | 1,866 | 3,321 | 5,921 |
| 2024 | ||||||
| Balance | Contractual | |||||
| sheet | cash flows | Between 1 | Between 2 | |||
| £ million | amount | total | <1 year | and 2 years | and 5 years | > 5 years |
| Non-derivative | ||||||
| financial liabilities: | ||||||
Bank loans | 34 | 34 | 34 | - | - | - |
Capital market issuance | 8,663 | 10,218 | 1,497 | 1,911 | 2,752 | 4,058 |
Trade payables | 1,499 | 1,499 | 1,499 | - | - | - |
Accruals | 924 | 924 | 838 | 14 | 72 | - |
Other contractual liabilities | 623 | 623 | 623 | - | - | - |
Lease liabilities | 386 | 435 | 96 | 82 | 144 | 113 |
| Total non-derivative | ||||||
financial liabilities | 12,129 | 13,733 | 4,587 | 2,007 | 2,968 | 4,171 |
£ million | 2025 | 2024 |
Adjusted net debt | 8,406 | 7,740 |
Equity attributable to the owners of the parent | 4,824 | 5,442 |
Total capital | 13,230 | 13,182 |
| 2025 | |||||
| Total notional | Between 1 | Between 2 | Maturity | ||
| £ million | balance | <1 year | and 2 years | and 5 years | > 5 years |
Capital market issuance | (5,703) | (567) | (1,399) | (1,674) | (2,063) |
Cross-currency swaps | (5,481) | - | (837) | (2,474) | (2,170) |
Foreign exchange swaps | (486) | (486) | - | - | - |
(11,670) | (1,053) | (2,236) | (4,148) | (4,233) |
| 2024 | |||||
| Maturity | |||||
| Total notional | Between 1 | Between 2 | |||
| £ million | balance | <1 year | and 2 years | and 5 years | > 5 years |
Capital market issuance | (4,595) | (438) | (1,103) | (2,120) | (934) |
Cross-currency swaps | (5,501) | (1,715) | (1,099) | (1,581) | (1,106) |
(10,096) | (2,153) | (2,202) | (3,701) | (2,040) |
| 2025 | |||||
| Carrying | |||||
| amount | |||||
| Changes in fair | |||||
| value used for | |||||
| Notional | calculating hedge | ||||
| £ million | balance | Assets | Liabilities | Balance sheet line item | in-effectiveness |
| Hedging instrument: | |||||
| Capital market | |||||
issuance | 5,703 | - | 5,764 | Borrowings | (99) |
| Bank Loans | - | - | - | Borrowings | (11) |
| Cross-currency swaps | 5,481 | - | 195 | Derivative financial | (265) |
| instruments | |||||
| Foreign exchange | 486 | 2 | - | Derivative financial | (2) |
| swaps | instruments | ||||
| Hedged item: | |||||
Investment in a foreign operation | n/a | 11,670 | - | (377) |
| 2024 | |||||
| Carrying | |||||
| amount | |||||
| Changes in fair | |||||
| value used for | |||||
| Notional | calculating hedge | ||||
| £ million | balance | Assets | Liabilities | Balance sheet line item | in-effectiveness |
| Hedging instrument: | |||||
| Capital market | |||||
issuance | 4,595 | - | 4,584 | Borrowings | 321 |
| Cross-currency swaps | 5,501 | 118 | 76 | Derivative financial | |
instruments | 213 | ||||
| Foreign exchange | - | - | - | Derivative financial | |
| swaps | instruments | 6 | |||
| Hedged item: | |||||
Investment in a foreign operation | n/a | 10,096 | - | 540 |
| 2025 | |||||
| Other | |||||
| At the beginning | Income | comprehensive | Designations/ | At the end | |
| £ million | of the year | statement | income | (de-designations) | of the year |
| Derivatives in net | |||||
investment hedges of foreign operations | 42 | 32 | (267) | - | (193) |
| Bonds in net investment | |||||
hedges of foreign operations | (4,584) | (71) | (110) | (999) | (5,764) |
Total | (4,542) | (39) | (377) | (999) | (5,957) |
| 2024 | |||||
| Other | |||||
| At the beginning | Income | comprehensive | Designations/ | At the end | |
| £ million | of the year | statement | income | (de-designations) | of the year |
| Derivatives in net | |||||
investment hedges of foreign operations | (248) | 71 | 219 | - | 42 |
| Bonds in net investment | |||||
hedges of foreign operations | (3,929) | 42 | 321 | (1,018) | (4,584) |
Total | (4,177) | 113 | 540 | (1,018) | (4,542) |
| 2025 | ||||
| Net financial | Related | |||
| Gross financial | assets/ | amounts not | ||
| assets/ | (liabilities) per | set-off in the | ||
| £ million | (liabilities) | balance sheet | balance sheet | Net |
| Assets | ||||
Derivative financial instruments | 437 | 437 | (436) | 1 |
| Liabilities | ||||
Derivative financial instruments | (834) | (834) | 436 | (398) |
| 2024 | ||||
| Net financial | Related amounts | |||
| Gross financial | assets/(liabilities) | not set-off in the | ||
| £ million | assets/(liabilities) | per balance sheet | balance sheet | Net |
| Assets | ||||
Derivative financial instruments | 474 | 474 | (462) | 12 |
| Liabilities | ||||
Derivative financial instruments | (809) | (809) | 462 | (347) |
| 2025 | ||||||
Fair value | ||||||
Fair value through other | Assets and | |||||
through income | comprehensive | liabilities at | ||||
| £ million | statement | income | amortised cost | Total | Current | Non-Current |
Trade and other receivables | 89 | - | 2,531 | 2,620 | 2,585 | 35 |
| Cash and cash | ||||||
equivalents | - | - | 1,439 | 1,439 | 1,439 | - |
Derivatives | 435 | 2 | - | 437 | 45 | 392 |
| Total financial | ||||||
assets | 524 | 2 | 3,970 | 4,496 | 4,069 | 427 |
Borrowings | - | - | (9,594) | (9,594) | (1,070) | (8,524) |
Trade and other payables | - | - | (3,324) | (3,324) | (3,283) | (41) |
Derivatives | (639) | (195) | - | (834) | (28) | (806) |
| Lease | ||||||
liabilities | - | - | (402) | (402) | (89) | (313) |
| Total financial | ||||||
liabilities | (639) | (195) | (13,320) | (14,154) | (4,470) | (9,684) |
| Total net | ||||||
| financial | ||||||
liabilities | (115) | (193) | (9,350) | (9,658) | (401) | (9,257) |
| 2024 | ||||||
Fair value | ||||||
Fair value through other | Assets and | |||||
through income | comprehensive | liabilities at | ||||
| £ million | statement | income | amortised cost | Total | Current | Non-Current |
Trade and other receivables | - | - | 2,524 | 2,524 | 2,487 | 37 |
| Cash and cash | ||||||
equivalents | - | - | 1,078 | 1,078 | 1,078 | - |
Derivatives | 356 | 118 | - | 474 | 144 | 330 |
| Total financial | ||||||
assets | 356 | 118 | 3,602 | 4,076 | 3,709 | 367 |
Borrowings | - | - | (8,697) | (8,697) | (1,191) | (7,506) |
Trade and other payables | - | - | (8,659) | (8,659) | (8,659) | - |
Derivatives | (733) | (76) | - | (809) | (187) | (622) |
| Lease | ||||||
liabilities | - | - | (386) | (386) | (86) | (300) |
| Total financial | ||||||
liabilities | (733) | (76) | (17,742) | (18,551) | (10,123) | (8,428) |
| Total net | ||||||
| financial | ||||||
| assets/ | ||||||
(liabilities) | (377) | 42 | (14,140) | (14,475) | (6,414) | (8,061) |
2025 | 2024 | |||||
| Net Fair | Net Fair | |||||
£ million | Assets | Liabilities | Value | Assets | Liabilities | Value |
| Current derivative | ||||||
| financial instruments: | ||||||
Interest rate swaps | 11 | (8) | 3 | 65 | (54) | 11 |
Foreign exchange contracts | 4 | (3) | 1 | 1 | (4) | (3) |
Cross-currency swaps | 30 | (17) | 13 | 78 | (129) | (51) |
Total current derivatives | 45 | (28) | 17 | 144 | (187) | (43) |
| Non-current derivative | ||||||
| financial instruments: | ||||||
Interest rate swaps | 242 | (263) | (21) | 240 | (365) | (125) |
Cross-currency swaps | 150 | (543) | (393) | 90 | (257) | (167) |
Total non-current derivatives | 392 | (806) | (414) | 330 | (622) | (292) |
| Total carrying value of derivative | ||||||
financial instruments | 437 | (834) | (397) | 474 | (809) | (335) |
| Analysed as: | ||||||
Interest rate swaps | 253 | (271) | (18) | 305 | (419) | (114) |
Foreign exchange contracts | 4 | (3) | 1 | 1 | (4) | (3) |
Cross-currency swaps | 180 | (560) | (380) | 168 | (386) | (218) |
| Total carrying value of derivative | ||||||
financial instruments | 437 | (834) | (397) | 474 | (809) | (335) |
| 2025 | ||||||
| Balance | Contractual | |||||
| sheet | cash flows | Between 1 | Between 2 | |||
| £ million | amount | total | <1 year | and 2 years | and 5 years | >5 years |
Net settled derivatives | (18) | (228) | (7) | (13) | (81) | (127) |
Gross settled derivatives | (379) | - | - | - | - | - |
• receipts | - | 22,490 | 3,176 | 3,056 | 8,467 | 7,791 |
• payments | - | (22,382) | (3,109) | (3,083) | (8,514) | (7,676) |
(397) | (120) | 60 | (40) | (128) | (12) |
| 2024 | ||||||
| Balance | Contractual | |||||
| sheet | cash flows | Between 1 | Between 2 | |||
| £ million | amount | total | <1 year | and 2 years | and 5 years | >5 years |
Net settled derivatives | (114) | 194 | 10 | 1 | 117 | 66 |
Gross settled derivatives | (221) | - | - | - | - | - |
• receipts | - | 20,719 | 6,490 | 2,730 | 5,762 | 5,737 |
• payments | - | (20,770) | (6,497) | (2,719) | (5,772) | (5,782) |
(335) | 143 | 3 | 12 | 107 | 21 |
£ million | 2025 | 2024 |
Foreign exchange (losses)/gains on borrowings | (110) | 321 |
Foreign exchange (losses)/gains on derivative financial instruments | (267) | 219 |
(377) | 540 |
| Consolidated | Consolidated | |||
| income | income | Consolidated | Consolidated | |
| statement | statement | balance sheet | balance sheet | |
£ million | 2025 | 2024 | 2025 | 2024 |
| Temporary differences on depreciation | ||||
and amortisation | 83 | (53) | (645) | (711) |
Retirement benefits | (12) | (5) | 41 | 48 |
Tax credits and losses | (146) | 393 | 455 | 579 |
| Accruals, provisions and other temporary | ||||
differences | 88 | (48) | 295 | 193 |
Deferred tax benefit | 13 | 287 | ||
Net deferred tax assets | 146 | 109 |
£ million | 2025 | 2024 |
Deferred tax assets | 893 | 889 |
Deferred tax liabilities | (747) | (780) |
146 | 109 |
£ million | 2025 | 2024 |
At 1 October | 109 | (218) |
Credited to the income statement | 13 | 287 |
(Charged)/credited to other comprehensive income | (3) | 36 |
Credited to equity | 4 | 2 |
Exchange movements | 23 | 2 |
As at 30 September | 146 | 109 |
£ million | Gross 2025 | Net 2025 | Gross 2024 | Net 2024 |
Tax losses | 105 | 21 | 245 | 64 |
Tax credits | 800 | 283 | 806 | 282 |
Other temporary differences | 68 | 22 | 77 | 22 |
973 | 326 | 1,128 | 368 |
£ million | Gross 2025 | Net 2025 | Gross 2024 | Net 2024 |
| Tax losses expiring: | ||||
Within 2-5 years | - | 1 | - | - |
No expiry | 105 | 20 | 245 | 64 |
105 | 21 | 245 | 64 | |
| Tax credits expiring: | ||||
No expiry | 800 | 283 | 806 | 282 |
800 | 283 | 806 | 282 | |
| Other temporary differences expiring: | ||||
No expiry | 68 | 22 | 77 | 22 |
68 | 22 | 77 | 22 |
2025 | 2024 | |||||
£ million | DBO | Assets | Total | DBO | Assets | Total |
At 1 October | (3,287) | 2,844 | (443) | (3,370) | 2,977 | (393) |
| Consolidated income statement expense: | ||||||
Current service cost | (19) | - | (19) | (18) | - | (18) |
Settlements gains/(losses) | 13 | (15) | (2) | 109 | (107) | 2 |
Past service income | - | - | - | 12 | - | 12 |
Cost of termination benefits | (6) | - | (6) | (2) | - | (2) |
Net interest (expense)/income on net defined benefit (liability)/asset | (149) | 138 | (11) | (171) | 160 | (11) |
Administration costs paid from plan assets | - | (6) | (6) | - | (5) | (5) |
Cost recognised in the income statement | (44) | (22) | ||||
| Remeasurements: | ||||||
Actuarial (loss)/gain due to liability experience | (64) | - | (64) | 13 | - | 13 |
Actuarial gain/(loss) due to financial assumption changes | 227 | - | 227 | (161) | - | (161) |
Actuarial gain due to demographic assumption changes | 31 | - | 31 | 1 | - | 1 |
Return on plan assets excluding amounts included in net interest (expense)/income above | - | (221) | (221) | - | 44 | 44 |
Remeasurement effects recognised in other comprehensive income | (27) | (103) | ||||
| Cash: | ||||||
Employer contributions | - | 57 | 57 | - | 55 | 55 |
Benefits paid | 253 | (253) | - | 247 | (247) | - |
Net cash | 57 | 55 | ||||
Changes to immaterial benefit plans categorised as an IAS 19 obligation recognised in the prior year | - | - | - | (11) | - | (11) |
Exchange movements | (32) | 2 | (30) | 64 | (33) | 31 |
Total other | (30) | 20 | ||||
At 30 September | (3,033) | 2,546 | (487) | (3,287) | 2,844 | (443) |
£ million | 2025 | 2024 |
Defined benefit expense in operating profit | 33 | 11 |
Defined contribution expense in operating profit | 23 | 23 |
Total retirement benefit scheme cost in operating profit | 56 | 34 |
£ million | 2025 | 2024 |
Cost of sales | 17 | 12 |
Distribution, advertising and selling costs | 25 | 13 |
Administrative and other expenses | 14 | 9 |
Total retirement benefit scheme costs in operating profit | 56 | 34 |
£ million | 2025 | 2024 |
Retirement benefit assets | 314 | 376 |
Retirement benefit liabilities | (801) | (819) |
Net retirement benefit liability | (487) | (443) |
2025 | 2024 | |||||
£ million unless otherwise indicated | ITPF | RCPP | ITG Scheme | ITPF | RCPP | ITG Scheme |
Defined benefit obligation (DBO) | 1,951 | 511 | 224 | 2,157 | 524 | 235 |
Fair value of scheme assets | (2,196) | - | (253) | (2,459) | - | (264) |
| Net defined benefit (asset)/ | ||||||
liability | (245) | 511 | (29) | (302) | 524 | (29) |
Current service cost | - | 9 | 2 | - | 7 | 2 |
Employer contributions | - | 24 | - | - | 23 | - |
| Principal actuarial assumptions | ||||||
| used (% per annum) | ||||||
Discount rate | 5.7 | 3.9 | 5.2 | 5.1 | 3.4 | 4.8 |
Future salary increases | n/a | 3.0 | n/a | n/a | 3.1 | n/a |
Future pension increases | 3.0 | 2.0 | n/a | 3.2 | 2.0 | n/a |
Inflation | 3.0 | 2.0 | 2.3 | 3.1 | 2.0 | 2.3 |
| 2025 | ||||||
ITPF | RCPP | ITG Scheme | ||||
Male | Female | Male | Female | Male | Female | |
| Life expectancy at age 65 years: | ||||||
Member currently aged 65 | 21.6 | 22.0 | 21.0 | 24.4 | 19.9 | 21.9 |
Member currently aged 50 | 22.4 | 23.1 | 23.1 | 26.0 | 21.1 | 23.1 |
| 2024 | ||||||
ITPF | RCPP | ITG Scheme | ||||
Male | Female | Male | Female | Male | Female | |
| Life expectancy at age 65 years: | ||||||
Member currently aged 65 | 21.2 | 22.6 | 20.9 | 24.3 | 19.8 | 21.9 |
Member currently aged 50 | 22.0 | 23.9 | 22.9 | 25.9 | 21.0 | 23.0 |
2025 | 2024 | |||||
% increase in DBO | ITPF | RCPP | ITG Scheme | ITPF | RCPP | ITG Scheme |
Discount rate: 0.5% decrease | 5.2 | 7.5 | 4.6 | 5.7 | 8.1 | 4.9 |
Rate of inflation: 0.5% decrease | (4.2) | (5.4) | n/a | (4.3) | (5.6) | n/a |
| One year increase in longevity | ||||||
for a member currently age 65, corresponding changes at other ages | 4.0 | 3.9 | 4.2 | 3.6 | 4.1 | 4.2 |
2025 | 2024 | |||
| Percentage of | Percentage of | |||
| ITPF scheme | ITPF scheme | |||
£ million unless otherwise indicated | Fair value | assets | Fair value | assets |
| Bonds - index linked government / | ||||
LDI funds | 444 | 20.2 | 487 | 19.8 |
Bonds - corporate and other | 114 | 5.2 | - | - |
Property including ground leases | 388 | 17.7 | 446 | 18.1 |
Secured finance and private debt funds | 303 | 13.7 | 463 | 18.8 |
Insurance contract (buy-in policy) | 926 | 42.2 | 1,035 | 42.1 |
| Other - including cash and short-term | ||||
loan drawings | 21 | 1.0 | 28 | 1.1 |
2,196 | 100.0 | 2,459 | 100.0 |
2025 | 2024 | |||
| Percentage of | ||||
| ITG Scheme | Percentage of ITG | |||
£ million unless otherwise indicated | Fair value | assets | Fair value | Scheme assets |
Bonds - government, corporate and other Other - including derivatives, | 134 | 53.0 | 122 | 46.2 |
commodities and cash | 119 | 47.0 | 142 | 53.8 |
253 | 100.0 | 264 | 100.0 |
| Employment | 2025 | |||
£ million | Restructuring | related claims | Other | Total |
At 1 October 2024 | 130 | 112 | 69 | 311 |
Additional provisions charged to the consolidated income statement | 1 | 14 | 12 | 27 |
Amounts used | (26) | (27) | (14) | (67) |
Unused amounts reversed | (9) | (13) | (10) | (32) |
Exchange movements | 5 | 5 | 3 | 13 |
At 30 September 2025 | 101 | 91 | 60 | 252 |
£ million | 2025 | 2024 |
Current | 55 | 89 |
Non-current | 197 | 222 |
252 | 311 |
2025 | 2024 | |||
| Ordinary shares | Ordinary shares | |||
| 10p each | 10p each | |||
Number | £ million | Number | £ million | |
| Authorised, issued and fully paid: | ||||
1 October | 914,502,882 | 91 | 968,590,194 | 97 |
Shares cancelled | (44,612,248) | (4) | (54,087,312) | (6) |
30 September | 869,890,634 | 87 | 914,502,882 | 91 |
£ million | 2025 | 2024 |
Share Matching Scheme | 2 | 2 |
Long Term Incentive Plan | 32 | 28 |
Sharesave Plan | 1 | 1 |
Discretionary Share Awards Plan | 1 | 1 |
36 | 32 |
| 2025 | |||||
| Sharesave | |||||
| Share | weighted | ||||
| Matching | average | ||||
| Scheme | Sharesave | DSAP | exercise | ||
| Thousands of shares unless otherwise indicated | awards | LTIP awards | options | awards | price £ |
Outstanding at 1 October 2024 | 371 | 8,565 | 1,540 | 211 | 14.78 |
Granted | 104 | 3,296 | 311 | 166 | 21.64 |
Cancelled/forfeited/lapsed | (15) | (1,171) | (75) | (15) | 14.80 |
Exercised | (167) | (2,383) | (231) | (75) | 14.36 |
Outstanding at 30 September 2025 | 293 | 8,307 | 1,545 | 287 | 16.22 |
Exercisable at 30 September 2025 | - | - | 34 | - | 14.56 |
| 2024 | |||||
| Sharesave | |||||
| Share | weighted | ||||
| Matching | average | ||||
| Scheme | Sharesave | exercise price | |||
| Thousands of shares unless otherwise indicated | awards | LTIP awards | options | DSAP awards | £ |
Outstanding at 1 October 2023 | 453 | 8,502 | 1,686 | 173 | 13.72 |
Granted | 172 | 4,341 | 445 | 73 | 15.96 |
Cancelled/forfeited/lapsed | (20) | (1,608) | (138) | (11) | 13.61 |
Exercised | (234) | (2,670) | (453) | (24) | 13.10 |
Outstanding at 30 September 2024 | 371 | 8,565 | 1,540 | 211 | 14.78 |
Exercisable at 30 September 2024 | - | - | 42 | - | 13.09 |
| Number of | Vesting period | Exercise price | |
| awards/options | remaining in | of options | |
| Thousands of shares unless otherwise indicated | outstanding | months | outstanding £ |
| Share Matching Scheme | |||
2023 | 109 | 5 | n/a |
2024 | 112 | 17 | n/a |
2025 | 72 | 29 | n/a |
Total awards outstanding | 293 | ||
| Long Term Incentive Plan | |||
2023 | 2,413 | 5 | n/a |
2024 | 3,256 | 17 | n/a |
2025 | 2,638 | 29 | n/a |
Total awards outstanding | 8,307 | ||
| Sharesave Plan | |||
2022 | 34 | - | 14.56 |
2023 | 786 | 10 | 14.29 |
2024 | 415 | 22 | 15.96 |
2025 | 310 | 34 | 21.64 |
Total options outstanding | 1,545 | ||
| Discretionary Share Awards Plan | |||
2023 | 58 | 6 | n/a |
2024 | 63 | 17 | n/a |
2025 | 166 | 29 | n/a |
Total options outstanding | 287 |
| Share Matching | 2025 | ||
Scheme | Sharesave | DSAP | |
Risk-free interest rate % | 4.0 | 3.7 | 3.9 |
Volatility (based on 3-year history)% | 20.0 | 19.0 | 19.7 |
Expected lives of options granted years | 3.0 | 3.0 | 3.0 |
Dividend yield % | 7.8 | 7.8 | 7.8 |
Fair value £ | 22.01 | 4.99 | 21.97 |
Share price used to determine exercise price £ | 27.80 | 29.09 | 27.75 |
Exercise price £ | n/a | 21.64 | n/a |
| 2024 | |||
| Share Matching | |||
Scheme | Sharesave | DSAP | |
Risk-free interest rate % | 4.2 | 4.3 | 4.2 |
Volatility (based on 3-year history)% | 25.0 | 24.1 | 25.0 |
Expected lives of options granted years | 3.0 | 3.0 | 3.0 |
Dividend yield % | 7.6 | 7. 6 | 7.6 |
Fair value £ | 14.56 | 3.40 | 14.55 |
Share price used to determine exercise price £ | 18.31 | 19.80 | 18.31 |
Exercise price £ | n/a | 15.96 | n/a |
% | 2025 | 2024 |
Future Imperial Brands share price volatility | 17.8 | 18.1 |
Share price volatility of the tobacco and alcohol comparator group | 14.0-24.7 | 15.4-23.1 |
| Correlation between Imperial Tobacco and the alcohol and tobacco | ||
comparator group | 21.0 | 18.9 |
Millions of shares | 2025 | 2024 |
At 1 October | 0.3 | 1.6 |
Gift of shares from Treasury | 5.7 | 2.0 |
Distribution of shares held by Employee Share Ownership Trusts | (3.0) | (3.3) |
At 30 September | 3.0 | 0.3 |
2025 | 2024 | |||
| Millions of | ||||
| Millions of | Value | shares | Value | |
| £ million unless otherwise indicated | shares (number) | £ | (number) | £ |
At 1 October | 68.3 | 2,183 | 70.3 | 2,183 |
| Gifted to Employee Share Ownership | ||||
Trusts | (5.7) | - | (2.0) | - |
At 30 September | 62.6 | 2,183 | 68.3 | 2,183 |
Percentage of issued share capital | 7.2 | n/a | 7. 5 | n/a |
£ million | 2025 | 2024 |
| Contracted but not provided for: | ||
Property, plant and equipment and software | 160 | 207 |
| Derivative | Liabilities from | ||||||
| Current | Non-current | financial | financing | Cash and cash | |||
| £ million | borrowings | Lease liabilities | borrowings | instruments | activities | equivalents | Total |
At 1 October 2024 | (1,191) | (386) | (7,506) | (335) | (9,418) | 1,078 | (8,340) |
Reallocation of current borrowings from non-current borrowings | (1,613) | - | 1,613 | - | - | - | - |
Cash flow | 1,774 | 109 | (2,438) | 144 | (411) | 310 | (101) |
Change in accrued interest | 12 | (15) | (38) | 3 | (38) | - | (38) |
Change in fair values | - | - | - | 8 | 8 | - | 8 |
New leases, terminations and modifications | - | (95) | - | - | (95) | - | (95) |
Exchange movements | (52) | (15) | (155) | (217) | (439) | 51 | (388) |
At 30 September 2025 | (1,070) | (402) | (8,524) | (397) | (10,393) | 1,439 | (8,954) |
| Derivative | Liabilities from | ||||||
| Current | Non-current | financial | financing | Cash and cash | |||
| £ million | borrowings | Lease liabilities | borrowings | instruments | activities | equivalents | Total |
At 1 October 2023 | (1,499) | (349) | (7,882) | (53) | (9,783) | 1,345 | (8,438) |
Reallocation of current borrowings from non-current borrowings | (1,673) | - | 1,673 | - | - | - | - |
Cash flow | 1,760 | 107 | (1,660) | 34 | 241 | (203) | 38 |
Change in accrued interest | 37 | (14) | (21) | 12 | 14 | - | 14 |
Change in fair values | - | - | - | (119) | (119) | - | (119) |
New leases, terminations and modifications | - | (144) | - | - | (144) | - | (144) |
Exchange movements | 184 | 14 | 384 | (209) | 373 | (64) | 309 |
At 30 September 2024 | (1,191) | (386) | (7,506) | (335) | (9,418) | 1,078 | (8,340) |
| 2025 | |||||
£ million | GBP | EUR | USD | Other | Total |
Cash and cash equivalents | 185 | 522 | 256 | 476 | 1,439 |
Total borrowings | (693) | (3,943) | (4,950) | (8) | (9,594) |
(508) | (3,421) | (4,694) | 468 | (8,155) | |
| Effect of cross-currency | |||||
swaps | 477 | (5,519) | 4,662 | - | (380) |
(31) | (8,940) | (32) | 468 | (8,535) | |
Lease liabilities | (36) | (291) | (37) | (38) | (402) |
| Derivative financial | |||||
instruments | (17) | ||||
Net debt | (8,954) |
| 2024 | |||||
£ million | GBP | EUR | USD | Other | Total |
Cash and cash equivalents | 356 | 179 | 129 | 414 | 1,078 |
Total borrowings | (1,014) | (3,383) | (4,291) | (9) | (8,697) |
(658) | (3,204) | (4,162) | 405 | (7,619) | |
| Effect of cross-currency | |||||
swaps | 1,022 | (5,532) | 4,292 | - | (218) |
364 | (8,736) | 130 | 405 | (7,837) | |
Lease liabilities | (39) | (265) | (47) | (35) | (386) |
| Derivative financial | |||||
instruments | (117) | ||||
Net debt | (8,340) |
£ million | 2025 | 2024 |
Increase/(decrease) in cash and cash equivalents | 310 | (203) |
Cash flows relating to derivative financial instruments | 144 | 34 |
Repayment of lease liabilities | 109 | 107 |
Increase in borrowings | (3,899) | (3,848) |
Repayment of borrowings | 3,235 | 3,948 |
Change in net debt resulting from cash flows | (101) | 38 |
| Other non-cash movements including revaluation of derivative | ||
financial instruments | (30) | (105) |
New leases, terminations and modifications | (95) | (144) |
Exchange movements | (388) | 309 |
Movement in net debt during the year | (614) | 98 |
Opening net debt | (8,340) | (8,438) |
Closing net debt | (8,954) | (8,340) |
Euro million | 2025 | 2024 |
Current assets | 6,575 | 6,290 |
Current liabilities | (7,251) | (6,990) |
Current net liabilities | (676) | (700) |
Non-current assets | 1,732 | 1,790 |
Non-current liabilities | (414) | (449) |
Non-current net assets | 1,318 | 1,341 |
Net assets | 642 | 641 |
Euro million | 2025 | 2024 |
Revenue | 13,536 | 12,986 |
Profit for the year | 281 | 308 |
Total comprehensive income | 281 | 308 |
Euro million | 2025 | 2024 |
Cash flows from operating activities | 601 | 397 |
Cash flows from investing activities | (223) | (51) |
Cash flows from financing activities | (373) | (370) |
Net increase/(decrease) in cash and cash equivalents | 5 | (24) |